SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CRMD

CorMedix Inc. (NASDAQ:CRMD)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$5.27+$0.19 (+3.74%)
 
Market cap
$419M
Insider Score
Health Score
Analyst consensus
Listed since
May 13, 2010
Market Cap$419.16M-46.3%
Revenue (ttm)$412.49M+92.5%
Net Income$63.89M-60.7%
EPS$0.68-67.0%
Shares Out79.54M
PE Ratio6.59
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,608,270
Open$4.96
Previous Close$5.08
Day's Range$4.95 - $5.32
52-Week Range$4.47 - $13.02
Beta1.48
AnalystsBuy
Price Target$15.33(+190.89%)
Earnings DateMar 4, 2027

About CRMD

CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.

Address
389 Interpace Pkwy, Parsippany, NJ, 07054, US
Market Cap
419 million
Employees
191
Industrial Classification
Biotechnology

CorMedix Inc. Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
94th Percentile Overall Score
CRMD InsiderScore:95 / 99

CorMedix Inc. scored higher than 94% of companies evaluated by InsiderBuying, and ranked 5th out of 110 stocks in the biotech sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at CorMedix Inc. bought $588.2K of stock across 4 purchases in the last 90 days, the largest of them $391.2K.

Stake Increase

The average purchase added about 8% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$68.80K
Bought
$588.20K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
2 Buy0 Hold0 SellAvg target $13.50 (+156.2%)

2 firms rating CRMD in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Strong
From CRMD’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
+3.74%
5 Days
+4.36%
1 Month
-34.94%
6 Months
-33.96%
1 Year
-46.33%

$CRMD stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CRMD holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CRMD's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CRMD Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New CRMD patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CRMD from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CRMD

AVUVAvantis U.S. Small Cap Value ETF$14.89M
IWMiShares Russell 2000 ETF$10.52M
VTIVanguard Morningstar Total Stock Market ETF$10.00M
VIRSPacer BioThreat Strategy ETF$4.93M
SZNEPacer CFRA-Stovall Equal Weight Seasonal Rotation ETF$4.93M
XPHState Street SPDR S&P Pharmaceuticals ETF$4.49M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from CRMD’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
94.96
Analyst Ratings
32% of score
85
News & Sentiment
20% of score
58

News check: Q3 revenue beat despite net loss, but analyst price targets cut from $15 to $13-14 while maintaining Outperform ratings. Product growth catalysts noted but tempered by valuation adjustments.

Recent Insider Activity

Buys
4
Sells
1
Buy Value
$588.20K
Distinct Buyers
4

Insider Score Trend Over Time

+12.6 since Nov 16
0255075100Nov 16 — Insider Score 82.3Nov 17 — Insider Score 81.1Nov 18 — Insider Score 79.6Nov 19 — Insider Score 87.4Nov 20 — Insider Score 86.7Nov 21 — Insider Score 94.9Nov 22 — Insider Score 95.0Nov 16Nov 19Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

XPHState Street SPDR S&P Pharmaceuticals ETF0.79%
FDMFirst Trust Dow Jones Select MicroCap Index Fund0.50%
GERMETFMG Treatments, Testing and Advancements ETF0.49%
AESLHarbor AlphaEdge Small Cap Value ETF0.25%
AESGHarbor AlphaEdge Small Cap Growth ETF0.22%
AESBHarbor AlphaEdge Small Cap Core ETF0.22%
AFSMFirst Trust Active Factor Small Cap ETF0.21%
SQLVRoyce Quant Small-Cap Quality Value ETF0.19%
BFORALPS ETF Trust - Barron's 400 ETF0.16%
PILLDirexion Daily Pharmaceutical & Medical Bull 3X ETF0.12%
ROSCHartford Multifactor Small Cap ETF0.11%
IWCiShares Micro-Cap ETF0.10%

Weight is the stock’s share of each fund’s holdings.